StockData
Lucid Diagnostics Inc. logo

Lucid Diagnostics Inc. (LUCD) stock

LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3034% above fair value
$0.40+0.00 (+0.30%)

Close on Nov 17, 2026Market cap $81.09MP/E –Yield –

Lucid Diagnostics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Lucid Diagnostics's operating cash flow for the twelve months ending Jun 30, 2026 was -$46.87M. For fiscal 2025 it was -$46.49M. The highest annual figure on record is -$5.63M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$46.49M–
FY2024Dec 31, 2024-$44.14M–
FY2023Dec 31, 2023-$32.82M–
FY2022Dec 31, 2022-$29.69M–
FY2021Dec 31, 2021-$17.67M–
FY2020Dec 31, 2020-$5.63M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$11.30M–
Q1 FY2026Mar 31, 2026-$12.10M–
Q4 FY2025Dec 31, 2025-$12.58M–
Q3 FY2025Sep 30, 2025-$10.89M–
Q2 FY2025Jun 30, 2025-$10.55M–
Q1 FY2025Mar 31, 2025-$12.47M–
Q4 FY2024Dec 31, 2024-$9.87M–
Q3 FY2024Sep 30, 2024-$10.18M–
Q2 FY2024Jun 30, 2024-$11.48M–
Q1 FY2024Mar 31, 2024-$12.61M–
Q4 FY2023Dec 31, 2023-$9.98M–
Q3 FY2023Sep 30, 2023-$8.78M–
Q2 FY2023Jun 30, 2023-$6.94M–
Q1 FY2023Mar 31, 2023-$7.12M–
Q4 FY2022Dec 31, 2022-$4.26M–
Q3 FY2022Sep 30, 2022-$6.35M–
Q2 FY2022Jun 30, 2022-$13.31M–
Q1 FY2022Mar 31, 2022-$5.78M–
Q4 FY2021Dec 31, 2021-$9.88M–
Q3 FY2021Sep 30, 2021-$2.18M–
Q2 FY2021Jun 30, 2021-$2.29M–
Q1 FY2021Mar 31, 2021-$3.32M–
Q4 FY2020Dec 31, 2020-$1.68M–

More Lucid Diagnostics figures

See a number that looks wrong?